Matches in SemOpenAlex for { <https://semopenalex.org/work/W2011603943> ?p ?o ?g. }
- W2011603943 endingPage "303" @default.
- W2011603943 startingPage "291" @default.
- W2011603943 abstract "Cervical cancer represents the third most common cause of female cancer mortality. Even with the best currently available treatment, a significant proportion of patients will experience recurrence and eventually die. Evidently, there is a clear need for the development of new agents with novel mechanisms of action in this disease. A number of biological agents modulating different signal transduction pathways are currently in clinical development, inhibiting angiogenesis, targeting epidermal growth factor receptor, cell cycle, histone deacetylases, cyclooxygenase-2 (COX-2), or mammalian target of rapamycin (mTOR). This is the first systematic review of the literature to synthesize all available data emerging from trials and evaluate the efficacy and safety of molecularly targeted drugs in cervical cancer. However, it should be stressed that relatively fewer molecularly targeted agents have been tested in cervical cancer in comparison with other cancer types; of note, no related phase 3 trials have been published and consequently no agent has been approved for use in clinical practice. Nevertheless, the promising results of bevacizumab in therapeutic trials for cervical cancer have shown that targeting the VEGF pathway is an attractive therapeutic strategy. As knowledge accumulates on the molecular mechanisms underlying carcinogenesis in the cervix, the anticipated development and assessment of molecularly targeted agents may offer a promising perspective for cervical cancer." @default.
- W2011603943 created "2016-06-24" @default.
- W2011603943 creator A5006991083 @default.
- W2011603943 creator A5030453966 @default.
- W2011603943 creator A5041466806 @default.
- W2011603943 creator A5046758725 @default.
- W2011603943 creator A5047824781 @default.
- W2011603943 date "2012-08-01" @default.
- W2011603943 modified "2023-09-25" @default.
- W2011603943 title "Molecularly targeted therapies in cervical cancer. A systematic review" @default.
- W2011603943 cites W1516432813 @default.
- W2011603943 cites W1539571840 @default.
- W2011603943 cites W1580361048 @default.
- W2011603943 cites W1840778568 @default.
- W2011603943 cites W1926137745 @default.
- W2011603943 cites W1965681130 @default.
- W2011603943 cites W1965757481 @default.
- W2011603943 cites W1969060819 @default.
- W2011603943 cites W1970457602 @default.
- W2011603943 cites W1970895498 @default.
- W2011603943 cites W1974556177 @default.
- W2011603943 cites W1975547066 @default.
- W2011603943 cites W1976864824 @default.
- W2011603943 cites W1978139448 @default.
- W2011603943 cites W1984034531 @default.
- W2011603943 cites W1984888076 @default.
- W2011603943 cites W1986440851 @default.
- W2011603943 cites W1986936335 @default.
- W2011603943 cites W1988548909 @default.
- W2011603943 cites W1996102081 @default.
- W2011603943 cites W1996475495 @default.
- W2011603943 cites W1997847937 @default.
- W2011603943 cites W2001309417 @default.
- W2011603943 cites W2004825554 @default.
- W2011603943 cites W2007672298 @default.
- W2011603943 cites W2007696702 @default.
- W2011603943 cites W2012784647 @default.
- W2011603943 cites W2014356708 @default.
- W2011603943 cites W2015919139 @default.
- W2011603943 cites W2018663191 @default.
- W2011603943 cites W2018866177 @default.
- W2011603943 cites W2020830322 @default.
- W2011603943 cites W2021684214 @default.
- W2011603943 cites W2022438732 @default.
- W2011603943 cites W2023826235 @default.
- W2011603943 cites W2041704644 @default.
- W2011603943 cites W2046421136 @default.
- W2011603943 cites W2049454219 @default.
- W2011603943 cites W2055499910 @default.
- W2011603943 cites W2056257367 @default.
- W2011603943 cites W2058601513 @default.
- W2011603943 cites W2060157525 @default.
- W2011603943 cites W2060794068 @default.
- W2011603943 cites W2062688626 @default.
- W2011603943 cites W2063194925 @default.
- W2011603943 cites W2065034264 @default.
- W2011603943 cites W2065186378 @default.
- W2011603943 cites W2068354564 @default.
- W2011603943 cites W2069950132 @default.
- W2011603943 cites W2071888464 @default.
- W2011603943 cites W2072199736 @default.
- W2011603943 cites W2076264206 @default.
- W2011603943 cites W2076955989 @default.
- W2011603943 cites W2077129920 @default.
- W2011603943 cites W2077498293 @default.
- W2011603943 cites W2077636251 @default.
- W2011603943 cites W2079101776 @default.
- W2011603943 cites W2079879369 @default.
- W2011603943 cites W2082601735 @default.
- W2011603943 cites W2087937285 @default.
- W2011603943 cites W2088885245 @default.
- W2011603943 cites W2090401278 @default.
- W2011603943 cites W2093207065 @default.
- W2011603943 cites W2098598713 @default.
- W2011603943 cites W2099011923 @default.
- W2011603943 cites W2100337624 @default.
- W2011603943 cites W2100823015 @default.
- W2011603943 cites W2108936162 @default.
- W2011603943 cites W2110444464 @default.
- W2011603943 cites W2111715042 @default.
- W2011603943 cites W2118863945 @default.
- W2011603943 cites W2120220319 @default.
- W2011603943 cites W2121082164 @default.
- W2011603943 cites W2129944002 @default.
- W2011603943 cites W2131571700 @default.
- W2011603943 cites W2133304803 @default.
- W2011603943 cites W2134796844 @default.
- W2011603943 cites W2142564546 @default.
- W2011603943 cites W2144016324 @default.
- W2011603943 cites W2144847294 @default.
- W2011603943 cites W2146404049 @default.
- W2011603943 cites W2149032069 @default.
- W2011603943 cites W2157511493 @default.
- W2011603943 cites W2157838504 @default.
- W2011603943 cites W2158134441 @default.
- W2011603943 cites W2160328599 @default.
- W2011603943 cites W2162424705 @default.
- W2011603943 cites W2167503494 @default.